Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Titan Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| Shares | 968.0K | 949.8K | −18.2K (−1.9%) |
| Value | $757.9K | $787.4K | +$29.5K (+3.9%) |
New holders (2)
Institutions that held Titan Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cape Investment Advisory, Inc. | 1 | $1 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (3)
Institutions that held Titan Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Virtu Financial LLC | 20,080 | $16.0K |
| The PNC Financial Services Group, Inc. | 200 | $156 |
| IFP Advisors, Inc | 14 | – |